Literature DB >> 23267671

Plucking the high hanging fruit: a systematic approach for targeting protein-protein interactions.

Monika Raj1, Brooke N Bullock, Paramjit S Arora.   

Abstract

Development of specific ligands for protein targets that help decode the complexities of protein-protein interaction networks is a key goal for the field of chemical biology. Despite the emergence of powerful in silico and experimental high-throughput screening strategies, the discovery of synthetic ligands that selectively modulate protein-protein interactions remains a challenge for bioorganic and medicinal chemists. This Perspective discusses emerging principles for the rational design of PPI inhibitors. Fundamentally, the approach seeks to adapt nature's protein recognition principles for the design of suitable secondary structure mimetics.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23267671      PMCID: PMC3622812          DOI: 10.1016/j.bmc.2012.11.023

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  111 in total

1.  Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion.

Authors:  Gary Frey; Sophia Rits-Volloch; X-Q Zhang; Robert T Schooley; Bing Chen; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

Review 2.  Translating p53 into the clinic.

Authors:  Chit Fang Cheok; Chandra S Verma; José Baselga; David P Lane
Journal:  Nat Rev Clin Oncol       Date:  2010-10-26       Impact factor: 66.675

Review 3.  Principles of protein-protein interactions: what are the preferred ways for proteins to interact?

Authors:  Ozlem Keskin; Attila Gursoy; Buyong Ma; Ruth Nussinov
Journal:  Chem Rev       Date:  2008-03-21       Impact factor: 60.622

4.  Atomic interactions and profile of small molecules disrupting protein-protein interfaces: the TIMBAL database.

Authors:  Alícia P Higueruelo; Adrian Schreyer; G Richard J Bickerton; Will R Pitt; Colin R Groom; Tom L Blundell
Journal:  Chem Biol Drug Des       Date:  2009-11       Impact factor: 2.817

5.  Protein clefts in molecular recognition and function.

Authors:  R A Laskowski; N M Luscombe; M B Swindells; J M Thornton
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

6.  Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis.

Authors:  H N Bramson; J Corona; S T Davis; S H Dickerson; M Edelstein; S V Frye; R T Gampe; P A Harris; A Hassell; W D Holmes; R N Hunter; K E Lackey; B Lovejoy; M J Luzzio; V Montana; W J Rocque; D Rusnak; L Shewchuk; J M Veal; D H Walker; L F Kuyper
Journal:  J Med Chem       Date:  2001-12-06       Impact factor: 7.446

7.  Direct and selective small-molecule activation of proapoptotic BAX.

Authors:  Evripidis Gavathiotis; Denis E Reyna; Joseph A Bellairs; Elizaveta S Leshchiner; Loren D Walensky
Journal:  Nat Chem Biol       Date:  2012-05-27       Impact factor: 15.040

8.  Oligobenzamide proteomimetic inhibitors of the p53-hDM2 protein-protein interaction.

Authors:  Jeffrey P Plante; Thomas Burnley; Barbora Malkova; Michael E Webb; Stuart L Warriner; Thomas A Edwards; Andrew J Wilson
Journal:  Chem Commun (Camb)       Date:  2009-06-24       Impact factor: 6.222

Review 9.  Bcl-2 inhibitors: small molecules with a big impact on cancer therapy.

Authors:  M Vogler; D Dinsdale; M J S Dyer; G M Cohen
Journal:  Cell Death Differ       Date:  2008-09-19       Impact factor: 15.828

10.  On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds.

Authors:  Tina R White; Chad M Renzelman; Arthur C Rand; Taha Rezai; Cayla M McEwen; Vladimir M Gelev; Rushia A Turner; Roger G Linington; Siegfried S F Leung; Amit S Kalgutkar; Jonathan N Bauman; Yizhong Zhang; Spiros Liras; David A Price; Alan M Mathiowetz; Matthew P Jacobson; R Scott Lokey
Journal:  Nat Chem Biol       Date:  2011-09-25       Impact factor: 15.040

View more
  27 in total

1.  High-resolution structures of a heterochiral coiled coil.

Authors:  David E Mortenson; Jay D Steinkruger; Dale F Kreitler; Dominic V Perroni; Gregory P Sorenson; Lijun Huang; Ritesh Mittal; Hyun Gi Yun; Benjamin R Travis; Mahesh K Mahanthappa; Katrina T Forest; Samuel H Gellman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

2.  HippDB: a database of readily targeted helical protein-protein interactions.

Authors:  Christina M Bergey; Andrew M Watkins; Paramjit S Arora
Journal:  Bioinformatics       Date:  2013-08-19       Impact factor: 6.937

3.  Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors.

Authors:  Jeffrey W Johannes; Stephanie Bates; Carl Beigie; Matthew A Belmonte; John Breen; Shenggen Cao; Paolo A Centrella; Matthew A Clark; John W Cuozzo; Christoph E Dumelin; Andrew D Ferguson; Sevan Habeshian; David Hargreaves; Camil Joubran; Steven Kazmirski; Anthony D Keefe; Michelle L Lamb; Haiye Lan; Yunxia Li; Hao Ma; Scott Mlynarski; Martin J Packer; Philip B Rawlins; Daniel W Robbins; Haidong Shen; Eric A Sigel; Holly H Soutter; Nancy Su; Dawn M Troast; Haiyun Wang; Kate F Wickson; Chengyan Wu; Ying Zhang; Qiuying Zhao; Xiaolan Zheng; Alexander W Hird
Journal:  ACS Med Chem Lett       Date:  2016-12-27       Impact factor: 4.345

Review 4.  Oncogenic protein interfaces: small molecules, big challenges.

Authors:  Tracy L Nero; Craig J Morton; Jessica K Holien; Jerome Wielens; Michael W Parker
Journal:  Nat Rev Cancer       Date:  2014-03-13       Impact factor: 60.716

Review 5.  Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

Authors:  Michelle R Arkin; Yinyan Tang; James A Wells
Journal:  Chem Biol       Date:  2014-09-18

6.  Synthesis of hydrogen-bond surrogate α-helices as inhibitors of protein-protein interactions.

Authors:  Stephen E Miller; Paul F Thomson; Paramjit S Arora
Journal:  Curr Protoc Chem Biol       Date:  2014-06-03

Review 7.  Protein Domain Mimics as Modulators of Protein-Protein Interactions.

Authors:  Nicholas Sawyer; Andrew M Watkins; Paramjit S Arora
Journal:  Acc Chem Res       Date:  2017-05-31       Impact factor: 22.384

8.  New Frontiers in Druggability.

Authors:  Dima Kozakov; David R Hall; Raeanne L Napoleon; Christine Yueh; Adrian Whitty; Sandor Vajda
Journal:  J Med Chem       Date:  2015-08-11       Impact factor: 7.446

9.  In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics.

Authors:  Brooke Bullock Lao; Ivan Grishagin; Hanah Mesallati; Thomas F Brewer; Bogdan Z Olenyuk; Paramjit S Arora
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

10.  RNA Polymerase Tags To Monitor Multidimensional Protein-Protein Interactions Reveal Pharmacological Engagement of Bcl-2 Proteins.

Authors:  Jinyue Pu; Jeffrey A Dewey; Abbas Hadji; James L LaBelle; Bryan C Dickinson
Journal:  J Am Chem Soc       Date:  2017-08-15       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.